MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%

Sector Heatmap

Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%

SPRC — SciSparc Ltd. Ordinary Shares

Nasdaq

SciSparc Ltd. Ordinary Shares

CompareBack to Screener
$4.43
-0.21(-4.53%)
O
4.44
H
4.50
L
4.34
V
5.98K
⏱️ End-of-day dataAs of Oct 8, 2026

Chart

About SPRC

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

IndustryCommon Stock
SectorNot available
IPO DateAug 27, 2021
Employees3
Stock ExchangeNasdaq
Ticker SymbolSPRC

Key Financial Statistics

Market Cap$2.74M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$2.98 - $43.65
52-Week Avg Volume395.0K
VWAP$4.44
Transactions136
Total Recorded Bars1,282 days